MedPath

The Influence of NPPA/NPPB Haplotype on Natriuretic Peptide Plasma Levels

Completed
Conditions
Anesthesia
Surgical Procedure, Operative
Registration Number
NCT04327258
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

Crosssectional study to analyse the genetic influence on levels of cardiac biomarkers (BNP, NT-proBNP).

Detailed Description

Background

Natriuretic peptides play an important role in risk stratification and management of patients undergoing non-cardiac surgery. However, due to genetic variability, the levels of these biomarkers may differ in individual patients with cardiac derangement. In the preoperative setting, genetic contribution to natriuretic peptide plasma level variability has not yet been determined.

Objective

The aim of this study is to assess genetic contribution to NP plasma level variability in a Swiss cohort.

Methods

Cross-sectional association study in a cohort of non-cardiac surgery patients.

This study is a Subproject of a prospective cohort study registered under the ID 041/09.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
437
Inclusion Criteria
  • 18 years and older
  • Written informed consent
  • Scheduled surgery

Exclusion Criteria

  • No informed consent
  • Cognitive impairment
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Influence of NPPA/NPPB haplotype on natriuretic peptide plasma levelsBlood samples collected at start of anesthetic procedure

Estimation of genetic effects on natriuretic peptide (BNP, NT-proBNP) plasma levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath